Fig. 4From: Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cellsCombined cell-therapy with MDSCs and Treg decreases inflammatory cytokine expression. Immunohistochemical staining was performed to measure the expression of interleukin (IL)-17, IL-6, tumor necrosis factor (TNF)-Îą and Foxp3 in skin, liver, lung, intestine tissue from each groups at 28Â days after BMT. (scale bar, 100Â ÎźM)Back to article page